held by the American Association for the Study of Liver Diseases. Using a survey of a nationally representative sample of ...

Ipsen announces Bylvay data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS: Paris, France Tuesday, November 19, 2024, 11:00 H ...

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced positive results from the SOLSTICE Phase 2 clinical trial evaluating ...

INTEGRIS-PSC featured in an oral late breaker presentation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- ...

Alcohol-related deaths in the U.S. nearly doubled from 1999 to 2020. The sharpest spike occurred among 25- to 34-year-olds (nearly fourfold), while individuals aged 55 to 64 had the highest rates. Men ...

Given the increasing prevalence and mortality rates, targeted strategies are needed to reduce this growing health burden in ...

AI can help doctors diagnose early cases of fatty liver disease, a new study says. An AI program trained to spot a leading ...

So, drinkers of the cheaper industrial brands are probably poorer, and as other sociological studies have shown, probably ...

New data from Barinthus Bio's HBV003 trial has demonstrated durable HBsAG loss in participants with chronic hepatitis B.

There aren't many biotechs that are more exciting than Viking Therapeutics (NASDAQ: VKTX) right now. Thanks to its ...